E. A. Hardin

Selexipag in the treatment of pulmonary arterial hypertension: design, development, and therapy

E. A. Hardin, K. Chin, 2016, Drug design, development and therapy.

Markers of Immune Function in Heart Transplantation: Implications for Immunosuppression and Screening for Rejection

E. A. Hardin, David X Zhuo, Katie Ginder, 2021, Current Heart Failure Reports.

Noninvasive Assessment of Cardiac Output: Accuracy and Precision of the Closed‐Circuit Acetylene Rebreathing Technique for Cardiac Output Measurement

B. Levine, E. A. Hardin, S. Jarvis, 2020, Journal of the American Heart Association.

DEVELOPING METHODS FOR ANTAGONIZING TNF-α AND IL-1β IN THE CENTRAL NERVOUS SYSTEM

E. A. Hardin, 2006 .

Diuretic Strategies in Acute Decompensated Heart Failure

E. A. Hardin, J. Grodin, E. Ashley Hardin, 2017, Current Heart Failure Reports.

Identifying Discordance of Right- and Left-Ventricular Filling Pressures in Patients With Heart Failure by the Clinical Examination

C. Ayers, M. Drazner, J. Thibodeau, 2021, Circulation. Heart failure.

Rethinking the Modern Cardiology Morbidity and Mortality Conference: Harmonizing Quality Improvement and Education.

E. A. Hardin, David A. McNamara, Hurst M. Hall, 2019, Journal of the American College of Cardiology.

Prognostic Value of Echocardiographic Variables Before and After Initiation of Parenteral Prostacyclin Therapy: An Observational Study.

E. A. Hardin, K. Chin, F. Torres, 2022, Chest.

Prognosis of pulmonary arterial hypertension patients with pericardial effusion before and after initiation of parenteral prostacyclin therapy

E. A. Hardin, K. Chin, S. Bartolome, 2023, Pulmonary Circulation.